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ANTERIOR CHAMBER PUNCTURE OF THE EYE ON PATIENTS 
WITHOUT TOXOPLASMOSIS. 
Results of the PCR, the C coefficient and capture assay. 
A.DUCASSZ - LTHZLLIZZ - C.MAKi CHEMLA - J.M.PINON- 
PURPOSE 
the autors study the results of the PCR, the C coefficient and 
the Ig A antibodies of 30 patients without toxoplasmosis. 
METHODS 
An anterior chamber puncture is operated on 30 patients 
undergoing cataract surgery. 
RESULTS 
Contrary to all expectations, some of the results tend towards 
evolutional toxoplasmosis. 
CONCLUSION 
The interest of these methods concerning the biological 
diagnosis of ocular toxoplasmosis is by no means being 
questioned by these results, yet they should be carefully 
interpreted. 
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Purpose: lntravitreal antibiotic is the mainstay of 
endophthalmitis treatment. Repeat injections should be based 
on the knowledege of tissue levels. The purpose of this study is 
to assess the value of aqueous and vitreous assay. 
Methods: Aqueous and vitreous were assayed for antibiotic at 
the time of reinjection of 5 patients with endophthalmitis. Most 
patients recieved vancomydn 2 mg and amikacin 0.4 mg : one 
recieved amikacin 1 mg and another vancomycin 1 mg. In one 
patient the injection was repeated at 24 hours and in 3, at 48 
hours. One patient received 3 injections. 
Results: Aqueous vancomycin varied from 6.4 to 90 mg / L, 
exceeding the bactetfocidal level for sensitive gram +ve 
organisms. Aqueous amikacin ranged from 2. 1 to 6.7 mg/L and 
therefore failed to provide adequate cover against some 
gram - ve organisms. In two patients vitreous vancomydn levels 
were 93 and 96 mg/L and in one the amikacin level was 21.3 
mgl L. 
Conclusions: Antibiotics such as amikacin and vancomycin are 
rapidly assayed by fluorescence polarfsation immunoassay. In 
the present study aqueous vanwmycin levels were well wnhin 
the therapeutic range and at times aproached retinotoxic levels 
(100 mg / L). The hiihest levels of aqueous amikadn also 
bordered on retinotoxic levels (20 mgl L) whereas the lowest 
were potentially subtherapeutic. The present study shows that 
aqueous and vitreous sampling within 24 - 46 hours of initiating 
therapy can provide a guide to the timing of future interventions. 
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Purpose: TO investigate the clinical and histological 
toxicity of the exposure of the rabbit corneal endothelium 
to anterior chamber injection of liposome-encapsulated 5- 
fluarauridine (IS-FUR) at concentration* of 1 mg/ml and 
0.38 mgfml and intravitreal injection of L5-FUR at 1 
mg/m1. 
M*thCdS: A total of 12 New Zealand white rabbits were 
divided in three groups: A) Anterior chamber injection of 
0.1 ml of LS-FUR (1 rig/ml). B) Rnterior chamber injection 
of 0.1 ml of LS-FUR (0.38 mg/ml), c) Intravitraa1 
injection of LS-FUR (1 mg/ml). we treated 3 eyes and 1 
control eye (injection of 0.1 ml of empty liposomes) for 
each group. We studied the clinical cornea1 edema 24 h 
after and sacrified the rabbits to study the endothelium 
using light microscopy (silver stain). 
R.‘“lt*: Treated groups: A) We did not observe clinical 
cornea1 edema, but we demonstrated a moderate irregular 
staining of endotheiial membranes, a moderate sign of 
toxicity. 8) We did not observe clinical edema, but we 
demonstrated a lower rrregu1.w staining Of endothelial 
lllWbJTZi"M, a moderate sign Of toxicity. C) we did not 
Observe clinical edema, and endothelial membranes were 
normal e"ch as the control group. 
Conclusions: Anterior chamber injection of lipoaome 
encapsulated 5-fluorouridine (LA-FUR) at concentrations of 
1 mg/ml and 0.38 mg/ml causes qclitic membranes and a 
moderate histological endothelium toxicity "hereaS 
intravitreal injection of L-SFUR (0.1 mg/ml) appears 
nontoxic for the cornea1 endothelium. 
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